Hosokawa Micron (6277) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
3 Oct, 2025Executive summary
Net sales for the interim period ended March 31, 2025, were ¥38,477 million, down 7.2% year-over-year, with operating profit at ¥3,573 million, down 5.4% year-over-year.
Bookings for powder processing and blown film businesses remained stable year-over-year, but overall profits declined due to a 12.2% YoY drop in powder processing net sales.
Profit attributable to owners of parent rose 10.5% year-over-year to ¥2,691 million, reaching a record high for the first half.
Comprehensive income for the interim period was ¥3,701 million, down 8.2% year-over-year.
Financial highlights
Consolidated bookings: ¥40.9 billion, down 0.6% YoY; net sales: ¥38.5 billion, down 7.2% YoY.
Gross profit for the interim period was ¥13,446 million, with a gross margin of 35%.
Operating profit: ¥3.57 billion, down 5.4% YoY; net income: ¥2.69 billion, up 10.5% YoY.
Operating profit margin was 9.3% for the interim period; net profit margin was 7.0%.
Foreign exchange effects contributed about 1% to bookings, net sales, and operating profit.
Outlook and guidance
Full-year forecast for fiscal 2025 projects net sales of ¥83,000 million, operating profit of ¥6,500 million, and profit attributable to owners of parent of ¥5,100 million.
Earnings per share for the full year are forecast at ¥344.96.
1H progress rates: net sales 46.4%, operating profit 55.0%, net income 52.8%.
Annual dividend forecast is ¥120 per share, unchanged from the previous year.
Latest events from Hosokawa Micron
- Sales up, profits down on higher costs and one-time loss; FY2026 outlook steady.6277
Q1 20266 Feb 2026 - Sales and profits fell, but comprehensive income surged; FY2026 profit recovery expected.6277
Q4 20257 Nov 2025 - Record sales and operating profit, but net profit fell; next year’s outlook is cautious.6277
Q4 20243 Oct 2025 - Strong sales growth and higher profits, but full-year outlook signals profit decline.6277
Q3 20243 Oct 2025 - Sales and profits declined, but comprehensive income soared on currency gains; major merger completed.6277
Q1 20253 Oct 2025 - Profit rose on lower extraordinary losses despite sales decline; treasury share buyback approved.6277
Q3 20253 Oct 2025